- Home
- BCTX vs FTHM Comparison
BCTX vs FTHM Comparison
Compare BCTX & FTHM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | BCTX | FTHM |
|---|---|---|
| Founded | 2014 | 2010 |
| Country | Canada | United States |
| Employees | 4 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Real Estate |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 26.6M | 28.8M |
| IPO Year | 2025 | 2020 |
Fundamental Metrics
Financial Performance| Metric | BCTX | FTHM |
|---|---|---|
| Price | $3.50 | $0.74 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 1 |
| Target Price | ★ $40.00 | $2.50 |
| AVG Volume (30 Days) | 127.0K | ★ 152.1K |
| Earning Date | 06-15-2026 | 05-12-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 32.71 |
| EPS | N/A | ★ N/A |
| Revenue | N/A | ★ $420,477,000.00 |
| Revenue This Year | N/A | $11.67 |
| Revenue Next Year | $380.95 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 25.45 |
| 52 Week Low | $0.63 | $0.40 |
| 52 Week High | $14.68 | $3.37 |
Technical Indicators
Market Signals| Indicator | BCTX | FTHM |
|---|---|---|
| Relative Strength Index (RSI) | 49.70 | 39.88 |
| Support Level | $2.98 | $0.70 |
| Resistance Level | $4.51 | $0.85 |
| Average True Range (ATR) | 0.26 | 0.07 |
| MACD | -0.04 | -0.02 |
| Stochastic Oscillator | 34.62 | 20.78 |
Price Performance
Historical ComparisonAbout BCTX BriaCell Therapeutics Corp.
BriaCell Therapeutics Corp is a clinical-stage biotechnology company focused on developing immunotherapies for cancer treatment, particularly breast cancer. The company's targeted immunotherapy program, Bria-IMT, is a targeted cell-based immunotherapy in end-stage clinical trials aiming to improve outcomes for patients with breast cancer. BriaCell also develops Bria-OTS, personalized off-the-shelf immunotherapies for breast and prostate cancer. BriaCell is involved in clinical collaborations to explore combination therapies for enhanced cancer treatment options.
About FTHM Fathom Holdings Inc.
Fathom Holdings Inc is a national, technology-driven, real estate services platform integrating residential brokerage, mortgage, title, and Software as a Service (SaaS) offerings to brokerages and agents by leveraging intelliAgent , proprietary cloud-based software. The Company's three operating and reportable segments: Real Estate Brokerage, Mortgage, and Title. The majority of revenue is from Real Estate Brokerage, which provides real estate brokerage services.